Life Sciences Collaborative Agreements and Acquisitions

Matthew B. Zisk

New York intellectual property and technology partner Matthew Zisk spoke at American Conference Institute's "7th Advanced Forum on Life Sciences Collaborative Agreements and Acquisitions: Maximizing Opportunities and Rewards in M&A, Licensing, Partnering Deals and Strategic Alliances."  The event was held February 27-28 in New York.  Mr. Zisk discussed "Overcoming Defects in IP That Have the Potential to Derail Life Sciences Transactions." Topics included ferreting out when IP rights are overstated by a partner company or acquisition target; employing techniques for clearly documenting what entities are involved and who owns what; detecting previous licensing activity; determining when use restrictions will adversely impact the business reasons for a partnership; identifying the IP and patents at issue and projecting how the target’s prior agreements can affect the value and terms of the transaction; avoiding pending litigation risks; and addressing the effects the America Invents Act might have on patent value.